Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.

about

Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q48344943

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Methylation-independent CHFR e ...... sis in acute myeloid leukemia.

@en

Methylation-independent CHFR e ...... sis in acute myeloid leukemia.

@nl

type

Item

label

Methylation-independent CHFR e ...... sis in acute myeloid leukemia.

@en

Methylation-independent CHFR e ...... sis in acute myeloid leukemia.

@nl

prefLabel

Methylation-independent CHFR e ...... sis in acute myeloid leukemia.

@en

Methylation-independent CHFR e ...... sis in acute myeloid leukemia.

@nl

P1476

Methylation-independent CHFR e ...... sis in acute myeloid leukemia.

@en

P2093

Dong-Ming Yao

http://www.w3.org/2001/XMLSchema#string

Hong Guo

http://www.w3.org/2001/XMLSchema#string

Ji-Chun Ma

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Xi-Xi Li

http://www.w3.org/2001/XMLSchema#string

Xiang-Mei Wen

http://www.w3.org/2001/XMLSchema#string

P2860

Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer

Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer

GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells.

An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia

Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: are we ready for a prognostically prioritized molecular classification?

Acute myeloid leukaemia.

Diagnostic and prognostic value of cytogenetics in acute myeloid leukemia.

CHFR: a key checkpoint component implicated in a wide range of cancers.

Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.

Epigenetic dysregulation of ID4 predicts disease progression and treatment outcome in myeloid malignancies.

P304

4707-4714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.26253

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29115660

http://www.w3.org/2001/XMLSchema#string